Publications Database

Kowalski J. et al. (2011)

Paliperidone palmitate in a child with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

October, 21(5), pp. 491-493

Lambrey S. et al. (2010)

Effectiveness of clozapine for the treatment of aggression in an adolescent with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(1), pp. 79-80.

Read Extract (New Window)

Luby J. et al. (2006)

Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 575-587

Read Abstract (New Window)

Malone R. P. , Harvey J. A. (2008)

Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 221-222

Read Extract (New Window)

Malone R. P. et al. (2007)

Ziprasidone in adolescents with autism: an open-label pilot study.

Journal of Child and Adolescent Psychopharmacology

17(6), pp. 779-790

Read Abstract (New Window)

Maloney A. , Mick E. , Frazier J. (2014)

Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

24(6), pp. 357–359.

Read Abstract (New Window)

Mankoski R. et al. (2013)

Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.

Journal of Child and Adolescent Psychopharmacology

23(8), pp. 572-576.

Read Abstract (New Window)

Marcus R. N. et al. (2011)

Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.

Journal of Child and Adolescent Psychopharmacology

21(3), pp. 229-236

Read Abstract (New Window)

Marrus N. et al. (2014)

Lack of effect of risperidone on core autistic symptoms: data from a longitudinal study.

Journal of Child and Adolescent Psychopharmacology

November, 24(9), pp. 513-518.

Read Abstract (New Window)

Martin A. et al. (1992)

Open-label quetiapine in the treatment of children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

9(2), pp. 99-107

Read Abstract (New Window)

Mehl-Madrona L. et al. (2010)

Micronutrients versus standard medication management in autism: A naturalistic case-control study.

Journal of Child and Adolescent Psychopharmacology

20(2), pp. 95-103.

Read Abstract (New Window) Read Full (New Window)

Meiri G. , Bichovsky Y. , Belmaker R. (2009)

Omega 3 fatty acid treatment in autism.

Journal of Child and Adolescent Psychopharmacology

19(4), pp. 449-451

Read Abstract (New Window)

Millard H. , McLaren J. L. , Coffey B. J. (2014)

Lurasidone treatment in a child with autism spectrum disorder with irritability and aggression.

Journal of Child and Adolescent Psychopharmacology

August, 24(6), pp. 354-356.

Read Abstract (New Window)

Nicolson R. , Craven-Thuss B. , Smith J. (2006)

A prospective, open-label trial of galantamine in autistic disorder.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 621-629

Read Abstract (New Window)

Orsagh-Yentis D. K. et al. (2011)

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Oswald D. P. , Sonenklar N. A. (2007)

Medication use among children with autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

17(3), pp. 348-355

Read Abstract (New Window)

Owley T. et al. (2006)

A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 517-552

Read Abstract (New Window)

Paavonen E. J. et al. (2003)

Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder.

Journal of Child and Adolescent Psychopharmacology

13(1), pp. 83-95

Read Abstract (New Window)

Parikh M. , Kolevzon A. , Hollander E. (2008)

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 157-178

Read Abstract (New Window)

Pearson D. A. et al. (2013)

Effects of extended release methylphenidate treatment on ratings of attention-deficit hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Journal of Child and Adolescent Psychopharmacology

23(5), pp. 337-351.

Read Abstract (New Window) Read Full (New Window)